Business Wire

Enigma Biomedical Group and Invicro Sign a Collaboration Agreement

TORONTO--(BUSINESS WIRE)--Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for ...
Business Wire

Enigma Biomedical Group and CBD Solutions Sign Memorandum of Understanding to License Novel Investigational Tau R4 Imaging Biomarker

TORONTO--(BUSINESS WIRE)--Enigma Biomedical Group (EBG) today announced execution of an Option Agreement to license CBD Solutions’s (CBD’s) Tau R4 imaging (TR4) biomarker CBD2115 . This option is ...
Financial Post

Enigma Biomedical Group Announces Appointment of Michael Reitermann to Their Board of Directors

TORONTO — Enigma Biomedical Group (EBG) today announced the appointment of Michael Reitermann to their Board of Directors effective December 1, 2019. Michael Reitermann’s passion for innovation and ...
Financial Post

Enigma Biomedical Group - USA Signs License Agreement with AbbVie for Novel 4R Tau PET Imaging Biomarkers

KNOXVILLE, Tenn. — Enigma Biomedical Group – USA (EBG-USA) today announced it has signed an exclusive license and option agreement with AbbVie for the development and potential commercialization of ...